Isobavachalcone and bavachinin from Psoraleae Fructus modulate Aβ42 aggregation process through different mechanisms in vitro

FEBS Letters

Volumn 587, Issue 18, 2013, Pages 2930-2935

  Chen, Xiumin ^a   Yang, Yanfang ^a   Zhang, Yingtao ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Aggregation inhibitor; Amyloid beta; Bavachinin; Isobavachalcone; Psoraleae Fructus

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BAVACHININ; ISOBAVACHALCONE; METHANOL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PSORALEAE FRUCTUS EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL DESTRUCTION; CHEMICAL PARAMETERS; CONTROLLED STUDY; DIMERIZATION; DRUG MECHANISM; DRUG STRUCTURE; FRUIT; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FIBRILLIZATION; PROTEIN POLYMERIZATION; PSORALEAE FRUCTUS; TWO HYBRID SYSTEM;

AΒ; AD; AGGREGATION INHIBITOR; ALZHEIMER'S DISEASE; AMYLOID BETA; AMYLOID-BETA PEPTIDE; BAKUCHIOL; BAVACHIN; BAVACHININ; BC; BCN; BKC; IBC; IPL; ISOBAVACHALCONE; ISOPSORALEN; METHANOL EXTRACT OF PSORALEAE FRUCTUS; NBIF; NEOBAVAISOFLAVONE; PFE; PL; PLD; PSORALEAE FRUCTUS; PSORALEN; PSORALIDIN; THIOFLAVIN T; THT;

AMYLOID BETA-PEPTIDES; CELL LINE; CELL SURVIVAL; CHALCONES; DRUGS, CHINESE HERBAL; FLAVONOIDS; FRUIT; HUMANS; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; PSORALEA;

EID: 84883487028     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.07.037     Document Type: Article

References (31)

1. M. Citron Alzheimer's disease: strategies for disease modification Nat. Rev. Drug Disc. 9 2010 387 398
2. D.X. Liu, Y.C. Xu, Y. Feng, H. Liu, X. Shen, K.X. Chen, J.P. Ma, and H.L. Jiang Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of β-amyloid peptide Biochemistry 45 2006 10963 10972
3. D.J. Selkoe Preventing Alzheimer's disease Science 337 2012 1488 1492
4. F. Mangialasche, A. Solomon, B. Winblad, P. Mecocci, and M. Kivipelto Alzheimer's disease: clinical trials and drug development Lancet Neurol. 9 7 2010 702 716
5. C.I. Stains, K. Mondal, and I. Ghosh Molecules that target beta-amyloid ChemMedChem 2 12 2007 1674 1692
6. T. Hamaguchi, K. Ono, A. Murase, and M. Yamada Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway Am. J. Pathol. 175 6 2009 2557 2565
7. Y. Porat, A. Abramowitz, and E. Gazit Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism Chem. Biol. Drug Des. 67 1 2006 27 37
8. S. Yin, C.Q. Fan, Y. Wang, L. Dong, and J.M. Yue Antibacterial prenylflavone derivatives from Psoralea corylifolia, and their structure-activity relationship study Bioorg. Med. Chem. 12 16 2004 4387 4392
9. G. Xiao, G. Li, L. Chen, Z. Zhang, J.J. Yin, T. Wu, Z. Cheng, X. Wei, and Z. Wang Isolation of antioxidants from Psoralea corylifolia fruits using high-speed counter-current chromatography guided by thin layer chromatography-antioxidant autographic assay J. Chromatogr., A 1217 34 2010 5470 5476
10. Y. Wang, C. Hong, C. Zhou, D. Xu, and H.B. Qu Screening antitumor compounds psoralen and isopsoralen from Psoralea corylifolia L. Seeds Evid. Based Complement. Alternat. Med. 2011 2011 363052
11. P.G. Latha, D.A. Evans, K.R. Panikkar, and K.K. Jayavardhanan Immunomodulatory and antitumour properties of Psoralea corylifolia seeds Fitoterapia 71 3 2000 223 231
12. S.H. Lim, T.Y. Ha, J. Ahn, and S. Kim Estrogenic activities of Psoralea corylifolia L. seed extracts and main constituents Phytomedicine 18 5 2011 425 430
13. M.H. Tsai, G.S. Huang, Y.C. Hung, L. Bin, L.T. Liao, and L.W. Lin Psoralea corylifolia extract ameliorates experimental osteoporosis in ovariectomized rats Am. J. Chin. Med. 35 4 2007 669 680
14. S.H. Lim, T.Y. Ha, S.R. Kim, J. Ahn, H.J. Park, and S. Kim Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats Br. J. Nutr. 101 7 2009 1031 1039
15. B. Ruan, L.Y. Kong, Y. Takaya, and M. Niwa Studies on the chemical constituents of Psoralea corylifolia L J. Asian Nat. Prod. Res. 9 1 2007 41 44
16. C.F. Qiao, Q.B. Han, J.Z. Song, S.F. Mo, L.D. Kong, H.F. Kung, and H.X. Xu Chemical fingerprint and quantitative analysis of fructus Psoraleae by high-performance liquid chromatography J. Sep. Sci. 30 6 2007 813 818
17. Y.F. Wang, B. Wu, J. Yang, L.M. Hu, Y.F. Su, and X.M. Gao A rapid method for the analysis of ten compounds in Psoralea corylifolia L. by UPLC Chromatographia 70 1-2 2009 199 204
18. L. Zhao, C. Huang, Z. Shan, B. Xiang, and L. Mei Fingerprint analysis of Psoralea corylifolia L. by HPLC and LC-MS J. Chromatogr., B 821 1 2005 67 74
19. Y.H. Choi, G.H. Yon, K.S. Hong, D.S. Yoo, C.W. Choi, W.K. Park, J.Y. Kong, Y.S. Kim, and S.Y. Ryu In vitro BACE-1 inhibitory phenolic components from the seeds of Psoralea corylifolia Planta Med. 74 11 2008 1405 1408
20. L.W. Wang, Y.F. Yang, and Y.T. Zhang Application of a yeast two-hybrid based screening system in the identification of amyloid-beta aggregation inhibitors in pharmaceutical plants J. Chin. Pharm. Sci. 20 2011 510 517
21. A.R. Ladiwala, J.S. Dordick, and P.M. Tessier Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways J. Biol. Chem. 286 5 2011 3209 3218
22. W.H. Dong, T.Y. Wang, F. Wang, and J.H. Zhang Simple, time-saving dye staining of proteins for sodium dodecyl sulfate-polyacrylamide gel electrophoresis using Coomassie blue PLoS ONE 6 8 2011 e22394
23. A.R. Ladiwala, J. Litt, R.S. Kane, D.S. Aucoin, S.O. Smith, S. Ranjan, J. Davis, W.E. Van Nostrand, and P.M. Tessier Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity J. Biol. Chem. 287 29 2012 24765 24773
24. M. Necula, R. Kayed, S. Milton, and C.G. Glabe Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct J. Biol. Chem. 282 14 2007 10311 10324
25. K. Ono, M.M. Condron, and D.B. Teplow Structure-neurotoxicity relationships of amyloid β-protein oligomers Proc. Natl. Acad. Sci. USA 106 2009 14745 14750
26. A.R. Ladiwala, J.C. Lin, S.S. Bale, A.M. Marcelino-Cruz, M. Bhattacharya, J.S. Dordick, and P.M. Tessier Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers J. Biol. Chem. 285 31 2010 24228 24237
27. D.E. Ehrnhoefer, J. Bieschke, A. Boeddrich, M. Herbst, L. Masino, R. Lurz, S. Engemann, A. Pastore, and E.E. Wanker EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15 6 2008 558 566
28. Y. Feng, X.P. Wang, S.G. Yang, Y.J. Wang, X. Zhang, X.T. Du, X.X. Sun, M. Zhao, L. Huang, and R.T. Liu Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation Neurotoxicology 30 6 2009 986 995
29. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Rémésy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clin. Nutr. 81 2005 230S 242S
30. S. Schaffer, and B. Halliwell Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations Genes Nutr. 7 2 2012 99 109
31. J.T. Zhu, R.C. Choi, G.K. Chu, A.W. Cheung, Q.T. Gao, J. Li, Z.Y. Jiang, T.T. Dong, and K.W. Tsim Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in preventing beta-amyloid-induced cell death J. Agric. Food Chem. 55 6 2007 2438 2445